


MGA Report Comes in at Number One at The Center for Biosimilars
MGA Report Comes in at Number One at The Center for Biosimilars The Center for Biosimilars has announced that MGA’s recent report, “How Patent Thickets Constrain the US Biosimilars Market and Domestic Manufacturing,” was the top-read article on its...
MGA Report Featured by The Center for Biosimilars
MGA Report Featured by The Center for Biosimilars On Thursday, The Center for Biosimilars, a sister site of The American Journal of Managed Care, published an article discussing the differences between the patent systems in the United States and Europe when it comes...
New White Paper Identifies Patent Thickets as Barrier to US Biosimilars Market and Domestic Manufacturing
New White Paper Identifies Patent Thickets as Barrier to US Biosimilars Market and Domestic Manufacturing Alex Brill and Christy Robinson | Washington, DC The white paper offers policy options to improve access to affordable biosimilar medicines. WASHINGTON,...